12 Cheap Healthcare Stocks to Buy Heading into 2026

3. Concentra Group Holdings Parent, Inc. (NYSE:CON)

Upside Potential as of December 5, 2025: 48.95%

Number of Hedge Fund Holders: 23

Share Price as of December 5, 2025: $19.47

As of December 7, Concentra Group Holdings Parent, Inc. (NYSE:CON) has a “Buy” or equivalent rating from all seven analysts covering the stock. While the target price ranges from $25 to $31, the median price target of $29 implies an upside potential of 48.95% from the current price.

After Concentra Group Holdings Parent, Inc. (NYSE:CON) announced its third-quarter results on November 6, several analysts reaffirmed their bullish outlook on the company. On November 10, Mizuho Securities maintained a Buy rating on the stock, with an unchanged price target of $28. Three days earlier, Joanna Gajuk, an analyst at Bank of America Securities, maintained a Buy rating on the company.

In the third quarter, Concentra Group Holdings Parent, Inc. (NYSE:CON) reported increases in revenue, net income, and adjusted EBITDA of 17%, 8.9%, and 17.1%, respectively. Additionally, the company recorded a rise not only in revenue per visit but also in patient volumes.

As stated by Keith Newton, CEO of Concentra Group Holdings Parent, Inc. (NYSE:CON),

“Building on our business growth in the first half of the year, our strong third quarter results delivered year-over-year increases in revenue, net income, and Adjusted EBITDA driven by visit and rate growth, as well as executing on our inorganic strategy.”

Concentra Group Holdings Parent, Inc. (NYSE:CON), based in Addison, Texas, is a provider of occupational health services in the U.S. Founded in 1979, the company operates Concentra Telemed, Concentra Pharmacy, and Concentra Medical Compliance Administration.